International Congress of Chemotherapy 19-ICCBERGERON, Michel G.The American journal of medicine. 1995, Vol 99, Num 6A, issn 0002-9343, 96 p.Conference Proceedings

Vision and reality of industry-academia interaction in CanadaFRIESEN, H.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.80S-6A.81S, issn 0002-9343Conference Paper

Targeting fungi : A challengeMEUNIER, F.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.60S-6A.67S, issn 0002-9343Conference Paper

Biofilm disease : Its clinical manifestation and therapeutic possibilities of macrolidesKOBAYASHI, H.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.26S-6A.30S, issn 0002-9343Conference Paper

Impact of molecular biology on antibiotic susceptibility : Testing and therapyCOURVALIN, P.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.21S-6A.25S, issn 0002-9343Conference Paper

Pasteur's legacyMONTAGNIER, L.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.4S-6A.5S, issn 0002-9343Conference Paper

An international perspective on antimicrobial resistanceWIEDEMANN, B.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.19S-6A, issn 0002-9343, -20SConference Paper

Combination of BRMs with chemotherapyTURSZ, T.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.56S-6A.58S, issn 0002-9343Conference Paper

P-glycoprotein : Its role in drug resistanceLING, V.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.41-6A.34, issn 0002-9343Conference Paper

Toward rapid real-time molecular diagnostic to guide smart use of antimicrobials : AntimicrobialsBOISSINOT, Maurice; BERGERON, Michel G.Current opinion in microbiology. 2002, Vol 5, Num 5, pp 478-482, issn 1369-5274, 5 p.Article

Immunopathogenic mechanisms of human immuno-deficiency virus disease : Implications for therapyFAUCI, A.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.59S-6A.60S, issn 0002-9343Conference Paper

Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumoniaERJIAN WANG; BERGERON, Yves; BERGERON, Michel G et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 5, pp 721-726, issn 0305-7453, 6 p.Article

Present status of biological response modifiers in cancerPARKINSON, D. R.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.54S-6A.56S, issn 0002-9343Conference Paper

The treatment of AIDS and cancer in the third millenniumGALLO, R. C.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.6S-6A.10S, issn 0002-9343Conference Paper

Clinical drug resistance : The role of factors other than P-glycoproteinKAYE, S. B.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.40S-6A.44S, issn 0002-9343Conference Paper

Promoting synergism in an era of changeWITTES, R. E.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.87S-6A.90S, issn 0002-9343Conference Paper

Funding, education, and training in the context of industry-academica relationsMAK, T. W.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.84S-6A.86S, issn 0002-9343Conference Paper

Rapid molecular theranostics in infectious diseasesPICARD, Francois J; BERGERON, Michel G.Drug discovery today. 2002, Vol 7, Num 21, pp 1092-1101, issn 1359-6446, 10 p.Article

Past, present, and future of antimicrobial agentsMOELLERING, R. C.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.11S-6A.18S, issn 0002-9343Conference Paper

The future for partnerships between universities and industryRICHMOND, M. H.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.81S-6A.83, issn 0002-9343Conference Paper

Overview : Therapeutic monoclonal antibodies and anticytokines in infectious diseasesYOUNG, L. S.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.52S-6A.53S, issn 0002-9343Conference Paper

Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patientsSAGINUR, Raphael; CROTEAU, Daniel; BERGERON, Michel G et al.Journal of thoracic and cardiovascular surgery. 2000, Vol 120, Num 6, pp 1120-1130, issn 0022-5223Article

Subchronic (26-and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal modelsPIRET, Jocelyne; LAFOREST, Geneviève; BUSSIERES, Martin et al.Journal of applied toxicology. 2008, Vol 28, Num 2, pp 164-174, issn 0260-437X, 11 p.Article

Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004DUONG, Michel; SIMARD, Marie; BERGERON, Yves et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 1, pp 252-262, issn 0066-4804Article

Do monoclonal antibodies and anticytokines still have a future in infectious diseases ?COHEN, J; HEUMANN, D; GLAUSER, M.-P et al.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.45S-6A.52S, issn 0002-9343Conference Paper